Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF
In the earlier Phase 2 trial, the highest dose tested (45 mg) produced 14.7% weight loss at 36 weeks, suggesting that longer treatment and dose optimization may yield further improvements
Without concurrent attention to muscle maintenance, bone health, and long-term lifestyle change, patients risk losing critical lean mass and regaining weight as mostly fat, which can ultimately worsen joint pain, weaken bone density, and compromise recovery
The higher the rated value of C, the lower the continuous discharge capacity of the battery
Both medications use the same active ingredient and work in a similar way